302943
Contraceptive use, decision-making and impulsivity in a community sample of women
Objective: To determine whether impulsivity is associated with hormonal contraceptive use.
Methods: 372 community-based women completed the Reproductive Health Questionnaire (RHQ), Risk Behavior Assessment (RBA) and the Eysenck Impulsivity Scale (EIS).
Results: The majority of participants (184/372; 49%) were African American. Mean age was 33 years (SD=10.4). The majority of women (87%) reported not using any method to avoid pregnancy (281/321). The majority reported that use or non-use of contraception was their individual decision (69%; 191/274); 22% of women reported that it was a joint decision involving themselves and their partners (61/274). A minority of women (3%) reported that their partner alone made the decision concerning contraception. Only 3% of women reported using dual methods in the past 12 months. The mean impulsivity score was higher (M=11.62, SD=4.13) for women who chose not to use any contraception compared to women who used any form (hormonal or non-hormonal) of contraception (M=10.2, SD=4.35), t(335) = 3.05, p=.0025. With respect to impulsivity and decision-making, women who reported making contraception decisions by themselves had higher mean impulsivity (M=11.25, SD 4.23) compared to women who made the decision jointly with their sexual partner (M=10.93, SD=4.10) and those whose partner made the decision (M=6.62, SD=5.85), F(2, 306) = 4.61, p=.01.
Conclusion: Women with high impulsivity are using hormonal contraception sub-optimally.
Learning Areas:
Social and behavioral sciencesLearning Objectives:
Identify aspects of impulsivity and impulse control as it relates to hormonal and non-hormonal contraception use.
Assess the impact of impulsivity on how women make decisions about contraception.
Keyword(s): Contraception, Partner Involvement
Qualified on the content I am responsible for because: I have been principal investigator on several grants related to issues of women, drug use, HIV/AIDS, and sexually transmitted infections. I conducted the analysis and writing for this abstract and I have 37 peer-reviewed publications that appear in Pub-Med.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.